2seventy bio, Inc. (TSVT)

2seventy bio Statistics

Total Valuation

2seventy bio has a market cap or net worth of $247.71 million. The enterprise value is $297.23 million.

Market Cap	247.71M
Enterprise Value	297.23M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

2seventy bio has 51.50 million shares outstanding. The number of shares has increased by 20.40% in one year.

Shares Outstanding	51.50M
Shares Change (YoY)	+20.40%
Shares Change (QoQ)	+5.65%
Owned by Insiders (%)	2.91%
Owned by Institutions (%)	93.04%
Float	50.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.64
Forward PS	2.25
PB Ratio	1.05
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.76, with a Debt / Equity ratio of 1.07.

Current Ratio	4.76
Quick Ratio	4.66
Debt / Equity	1.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -51.89% and return on invested capital (ROIC) is -20.82%.

Return on Equity (ROE)	-51.89%
Return on Assets (ROA)	-19.01%
Return on Capital (ROIC)	-20.82%
Revenue Per Employee	$161,022
Profits Per Employee	-$570,270
Employee Count	274
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +123.72% in the last 52 weeks. The beta is 1.78, so 2seventy bio's price volatility has been higher than the market average.

Beta (5Y)	1.78
52-Week Price Change	+123.72%
50-Day Moving Average	4.76
200-Day Moving Average	4.64
Relative Strength Index (RSI)	47.84
Average Volume (20 Days)	227,120

Short Selling Information

The latest short interest is 5.42 million, so 10.52% of the outstanding shares have been sold short.

Short Interest	5.42M
Short Previous Month	5.32M
Short % of Shares Out	10.52%
Short % of Float	10.84%
Short Ratio (days to cover)	16.29

Income Statement

In the last 12 months, 2seventy bio had revenue of $44.12 million and -$156.25 million in losses. Loss per share was -$3.02.

Revenue	44.12M
Gross Profit	-134.41M
Operating Income	-186.14M
Pretax Income	-156.25M
Net Income	-156.25M
EBITDA	-176.56M
EBIT	-186.14M
Loss Per Share	-$3.02

Balance Sheet

The company has $201.87 million in cash and $251.40 million in debt, giving a net cash position of -$49.52 million or -$0.96 per share.

Cash & Cash Equivalents	201.87M
Total Debt	251.40M
Net Cash	-49.52M
Net Cash Per Share	-$0.96
Equity (Book Value)	234.80M
Book Value Per Share	4.56
Working Capital	177.67M

Cash Flow

In the last 12 months, operating cash flow was -$150.13 million and capital expenditures -$4.49 million, giving a free cash flow of -$154.61 million.

Operating Cash Flow	-150.13M
Capital Expenditures	-4.49M
Free Cash Flow	-154.61M
FCF Per Share	-$3.00

Margins

Gross Margin	n/a
Operating Margin	-421.88%
Pretax Margin	-354.16%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-350.04%

Dividends & Yields

2seventy bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.40%
Shareholder Yield	-20.40%
Earnings Yield	-63.08%
FCF Yield	-62.42%

Analyst Forecast

The average price target for 2seventy bio is $10.40, which is 116.22% higher than the current price. The consensus rating is "Buy".

Price Target	$10.40
Price Target Difference	116.22%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	12.47%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

2seventy bio has an Altman Z-Score of -1.64 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.64
Piotroski F-Score	1